• Illumina Launches Research Test Codeveloped with Merck to Unlock Deeper Insights into the Tumor Genome

    11 days ago - By San Diego Biotechnology

    New assay brings validated HRD technology from Myriad Genetics to the Illumina TruSight™ Oncology 500, a single, comprehensive pan-cancer test to identify key variants critical for cancer development and progression SAN DIEGO, June 22, 2022...
    Read more ...